Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.
Gao LR, Tian Y, Wang MS, Xia WL, Qin SR, Song YW, Wang SL, Tang Y, Fang H, Tang Y, Qi SN, Yan LL, Liu YP, Jing H, Chen B, Xing NZ, Li YX, Lu NN.
Gao LR, et al.
Front Oncol. 2023 Jan 19;13:1039901. doi: 10.3389/fonc.2023.1039901. eCollection 2023.
Front Oncol. 2023.
PMID: 36741014
Free PMC article.